FBXO22 and lung carcinoma: Additionally, immunohistochemical (IHC) staining of paired tissue samples collected from our lung adenocarcinoma patients also indicated that the expression of FBXO22 was dramatically elevated in lung cancer tissues (Fig. 1E).